H. Kuribara et Y. Uchihashi, INTERACTIONS OF OPIOIDS WITH CAFFEINE - EVALUATION BY AMBULATORY ACTIVITY IN MICE, Journal of Pharmacy and Pharmacology, 46(2), 1994, pp. 141-144
Morphine (up to 10 mg kg(-1)), buprenorphine (up to 0.1 mg kg(-1)), pe
ntazocine (30 mg kg(-1)) and caffeine (up to 10 mg kg(-1)), significan
tly increased mouse ambulation. The combination of morphine, buprenorp
hine and pentazocine with caffeine generally enhanced the effect. Dopa
mine D-1- and D-2-receptor bockade, depletion of stored dopamine, and
inhibition of dopamine synthesis could reduce the ambulation increased
by single administration of morphine, buprenorphine and caffeine, and
by combined administration of morphine and buprenorphine with caffein
e. Although naloxone (0.1-3 mg kg(-1)) itself did not change mouse amb
ulation, at 3 mg kg(-1), it reduced the effect of caffeine. The repeat
ed administration of morphine (10 mg kg(-1)) induced a sensitization t
o the ambulation-increasing effect, and was inhibited by the combinati
on of caffeine (10 mg kg(-1)) in the repeated administration schedule.
The repeated administration of caffeine (10 mg kg(-1)) with buprenorp
hine (0.3 mg kg(-1)) resulted in a decrease in the effect to the level
of caffeine alone. The development of cross-sensitization to morphine
(10 mg kg(-1)) by the repeated treatment with buprenorphine (0.3 mg k
g(-1)) was inhibited by caffeine (10 mg kg(-1)). Our results suggest t
hat the dopaminergic systems are involved in the enhanced interaction
of opioids having agonistic action on mu- or sigma- receptors with caf
feine. However, it is also considered that, following the repeated adm
inistration, caffeine acts to reduce the sensitivity to the ambulation
-increasing effect of opioids, probably inducing up-regulation of aden
osinergic systems.